RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+16.1%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$1.62B
AUM Growth
+$1.62B
(+5.1%)
Cap. Flow
-$63.6M
Cap. Flow
% of AUM
-3.93%
Top 10 Holdings %
Top 10 Hldgs %
46.04%
Holding
74
New
14
Increased
22
Reduced
20
Closed
12
Top Buys
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$66.3M |
| 2 |
Centene
CNC
|
$31.8M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
$27.9M |
| 4 |
Edwards Lifesciences
EW
|
$25.8M |
| 5 |
iRhythm Technologies
IRTC
|
$20.2M |
Top Sells
| 1 |
Puma Biotechnology
PBYI
|
$75.6M |
| 2 |
Incyte
INCY
|
$41.1M |
| 3 |
Neurocrine Biosciences
NBIX
|
$28.3M |
| 4 |
Molina Healthcare
MOH
|
$22.2M |
| 5 |
IMMU
Immunomedics Inc
IMMU
|
$21.9M |
Sector Composition
| 1 | Healthcare | 89.8% |
| 2 | Financials | 1.42% |
| 3 | Communication Services | 0.7% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $135M | 8.2% | 16,093,786 +3,327,924 | +26% | +$27.9M |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $121M | 7.38% | 12,043,932 +668,080 | +6% | +$6.73M |
|
3
Penumbra
PEN
$10.6B
| $81.7M | 4.98% | 931,444 -102,964 | -10% | -$9.04M |
|
|
4
Puma Biotechnology
PBYI
$254M
| $75.2M | 4.58% | 860,456 -864,958 | -50% | -$75.6M |
|
|
CLVS
5
DELISTED
Clovis Oncology, Inc.
CLVS
| $71.6M | 4.36% | 764,389 -208,307 | -21% | -$19.5M |
|
|
JUNO
6
DELISTED
Juno Therapeutics, Inc.
JUNO
| $66.3M | 4.04% | +2,219,616 | New | +$66.3M |
|
|
7
Molina Healthcare
MOH
$9.8B
| $57.3M | 3.49% | 828,574 -321,153 | -28% | -$22.2M |
|
|
SYNH
8
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $49.2M | 3% | 841,418 +207,639 | +33% | +$12.1M |
|
|
GWPH
9
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $44.6M | 2.72% | 444,936 +112,392 | +34% | +$11.3M |
|
10
Elevance Health
ELV
$71.8B
| $43.6M | 2.66% | 231,886 +56,558 | +32% | +$10.6M |
|
11
Wave Life Sciences
WVE
$1.53B
| $41.4M | 2.52% | 2,224,407 +953,310 | +75% | +$17.7M |
|
12
Atara Biotherapeutics
ATRA
$84.6M
| $38.3M | 2.33% | 2,734,044 -74 | -0% | -$1.04K |
|
|
IMGN
13
DELISTED
Immunogen Inc
IMGN
| $37.1M | 2.26% | 5,212,736 +1,228,002 | +31% | +$8.73M |
|
|
OXFD
14
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $36.3M | 2.21% | 2,155,949 +151,100 | +8% | +$2.54M |
|
15
Agios Pharmaceuticals
AGIO
$2.19B
| $35M | 2.13% | 681,165 -221,413 | -25% | -$11.4M |
|
|
SGEN
16
DELISTED
Seagen Inc. Common Stock
SGEN
| $34.4M | 2.09% | 665,139 -31,247 | -4% | -$1.62M |
|
17
Regenxbio
RGNX
$451M
| $33.9M | 2.07% | 1,718,671 +449,540 | +35% | +$8.88M |
|
|
18
Centene
CNC
$14.3B
| $31.8M | 1.94% | +398,200 | New | +$31.8M |
|
|
ELGX
19
DELISTED
Endologix Inc
ELGX
| $31M | 1.88% | 6,368,299 +3,650,905 | +134% | +$17.7M |
|
20
Boston Scientific
BSX
$156B
| $30.4M | 1.85% | 1,094,983 -105,116 | -9% | -$2.91M |
|
|
BOLD
21
DELISTED
Audentes Therapeutics, Inc
BOLD
| $27.9M | 1.7% | 1,459,616 +638,780 | +78% | +$12.2M |
|
22
Prothena Corp
PRTA
$441M
| $27.6M | 1.68% | 509,698 -339,785 | -40% | -$18.4M |
|
|
23
Edwards Lifesciences
EW
$47.8B
| $25.8M | 1.57% | +218,000 | New | +$25.8M |
|
|
ALDR
24
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $25.5M | 1.55% | 2,223,811 +313,925 | +16% | +$3.59M |
|
25
Xencor
XNCR
$580M
| $25.1M | 1.53% | 1,187,494 -405,032 | -25% | -$8.55M |
|